BC200 knockdown markedly reduced CD123+CD34+ cells, which was related to the malignant clonal cells with aberrant differentiation, excessive proliferation, and decreased apoptosis in MDS (Fig. 6I and Fig. S5A). The gene discussed is BCYRN1; the disease is myelodysplastic syndrome.